Efg Asset Management (Americas) Corp. Sage Therapeutics, Inc. Transaction History

Efg Asset Management (Americas) Corp.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$26.15 - $77.24 $791,377 - $2.34 Million	-30,263 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$60.18 - $154.77 $516,585 - $1.33 Million	8,584 Added 39.6%	30,263 $2.19 Million
Q3 2019 Nov 05, 2019	BUY	$140.29 - $189.96 $174,801 - $236,690	1,246 Added 6.1%	21,679 $3.04 Million
Q2 2019 Jul 09, 2019	BUY	$157.85 - $183.09 $38,515 - $44,673	244 Added 1.21%	20,433 $3.74 Million
Q1 2019 Apr 05, 2019	BUY	$89.33 - $163.65 $1.8 Million - $3.3 Million	20,189 New	20,189 $3.21 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.